Health News
Making MDS Treatment Decisions Easier
A big challenge with cancer treatment has to do with knowing whether or not the patient will respond well to treatment. Scientists have come up with a model that answers this question for one disorder that can lead to cancer.
Leukemia Rx May Work Well
Chronic lymphocytic leukemia is a type of blood cancer that usually grows slowly and can be treated with chemotherapy. But in some cases, patients do not respond to this traditional treatment.
Updating Info on CML Rx
Chronic myeloid leukemia (CML) was once a dire diagnosis. Now the disease can be treated successfully in most people. The disease has to be treated over many years to be kept under control.
Pumping Iron for the Baby
Many pregnant women take prenatal supplements. Some contain iron while others may not. The amount of iron a woman needs during pregnancy is important to discuss with her care provider.
Good Old Aspirin Can Do the Trick
Successful recovery after hip replacement surgery depends on good medical care to avoid problems such as infection and blood clots. There are prescription medications to prevent blood clots, but a common over-the-counter pill may be as good a choice.
These Cells Can Stem Blood Cancer
Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite.
Need for Warfarin is in the Genes
DNA varies from person to person and, in some ways, group to group. Those variations may explain why many blacks require much less of a widely prescribed blood thinner than do whites.
On the Road to Bariatric Success?
Bariatric surgery brings the benefit of extraordinary weight loss, but it also carries some health hazards. One risk is blood clots, which may be avoided through various methods, some more effective than others.
New and Improved Leukemia Rx
Though more common in adults, acute myeloid leukemia (AML) is the second most common type of blood cancer in children. If untreated, the disease can be fatal in just a few months.
Non-Hodgkin Rx Trial Halted
A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.